Skip to main content
OpenTrials

Clinical trial condition

Craniosynostoses

Explore clinical trials studying Craniosynostoses. Study availability and eligibility vary by location and protocol.

20 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Craniosynostoses trial results

Recruiting

A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1

NCT07292168

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +45 more
Locations
  • Republican Dispensary of Tatarstan Kazan', Russia
  • A.I. Kryzhanovsky Krasnoyarsk Regional Cancer Center Krasnoyarsk, Russia
  • Hadassah Medical Moscow, Russia
  • I.P. Pavlov First Saint Petersburg State Medical University Saint Petersburg, Russia
View Trial Details
Recruiting

NCCH2006/MK010 Trial (FORTUNE Trial)

NCT04962867

Conditions
Acrocephalosyndactylia, Advanced or Recurrent Solid Tumors, Bone Diseases, +12 more
Locations
  • National Cancer Center Hospital Chuo-ku, Tokyo, Japan
  • Kanagawa Cancer Center Yokohama, Kanagawa, Japan
  • Tohoku University Hospital Aoba-ku, Sendai, Miyagi, Japan
  • Kyushu University Hospital Higashi-Ku, Fukuoka, Japan
View Trial Details
Recruiting

Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations

NCT06160752

Conditions
Acrocephalosyndactylia, Adenocarcinoma, Bone Diseases, +24 more
Locations
  • University of California San Francisco (UCSF) San Francisco, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • The Ohio State University Columbus, Ohio, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

A Study of E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer

NCT04572295

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +16 more
Locations
  • Eisai Trial Site 11 Nagoya, Aichi-ken, Japan
  • Eisai Trial Site 6 Kashiwa, Chiba, Japan
  • Eisai Trial Site 9 Matsuyama, Ehime, Japan
  • Eisai Trial Site 5 Yokohama, Kanagawa, Japan
View Trial Details
Completed

A Study of E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor (FGFR) 2 Gene Fusion

NCT04238715

Conditions
Acrocephalosyndactylia, Adenocarcinoma, Bone Diseases, +16 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Beijing Tsinghua Chang Gung Memorial Hospital Beijing, Beijing Municipality, China
  • Beijing Youan Hospital Affiliated to Capital Medical University Beijing, Beijing Municipality, China
View all 56 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)

NCT02872714

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +16 more
Locations
  • Arizona Oncology Associates (Wilmot) Tucson, Arizona, United States
  • Sharp Memorial Hospital San Diego, California, United States
  • UCSF Helen Diller Family Comprehensive Care Center San Francisco, California, United States
  • Rocky Mountain Cancer Centers Boulder, Colorado, United States
View all 96 locations
View Trial Details

Related conditions